Ina Rothenaigner - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ina Rothenaigner

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Nature Communications|December 20, 2024

Reliability of high-quantity human brain organoids for modeling microcephaly, glioma invasion and drug screeningAnand Ramani, Giovanni Pasquini, Niklas J Gerkau, et al.

Iscience|February 2, 2026

<i>In vitro</i> model of human subcutaneous adipocyte spheroids for studying mitochondrial dysfunction and mitochondria activating compoundsAnita Wagner, Juulia H Lautaoja-Kivipelto, Kalle Pehkonen, et al.

Cell Chemical Biology|January 12, 2022

Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronavirusesValeria Napolitano, Agnieszka Dabrowska, Kenji Schorpp, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Nature Communications|December 20, 2024

Reliability of high-quantity human brain organoids for modeling microcephaly, glioma invasion and drug screeningAnand Ramani, Giovanni Pasquini, Niklas J Gerkau, et al.

Iscience|February 2, 2026

Cell Chemical Biology|January 12, 2022

Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronavirusesValeria Napolitano, Agnieszka Dabrowska, Kenji Schorpp, et al.

Pageof 4